Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
- Status
- COMPLETED
- Phase
- N/A
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE3
Proton Beam Therapy for Treatment of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC
- Status
- UNKNOWN
- Phase
- NA
HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC
- Status
- COMPLETED
- Phase
- N/A
Alternative Surgical Policy for Central Liver Tumors
- Status
- COMPLETED
- Phase
- N/A
Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
- Status
- TERMINATED
- Phase
- PHASE1
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
- Status
- UNKNOWN
- Phase
- PHASE3
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.
- Status
- COMPLETED
- Phase
- NA